Chemoinformaics analysis of N-COUMARYL-QUINIC-ACID
| Molecular Weight | 302.458 | nRot | 1 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 18 |
| Exact Molecular Weight | 302.225 | nRing | 3 |
| Solubility: LogS | -4.709 | nHRing | 0 |
| Solubility: LogP | 4.466 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 55.0078 |
| nHD | 1 | BPOL | 30.9642 |
| QED | 0.709 |
| Synth | 4.217 |
| Natural Product Likeliness | 2.922 |
| NR-PPAR-gamma | 0.698 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.151 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -5.032 |
| MDCK | 0.0000136 |
| BBB | 0.084 |
| PPB | 0.957667 |
| VDSS | 0.671 |
| FU | 0.0282038 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.869 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.912 |
| CYP2c9-inh | 0.196 |
| CYP2c9-sub | 0.671 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.495 |
| CYP3a4-inh | 0.09 |
| CYP3a4-sub | 0.453 |
| CL | 0.665 |
| T12 | 0.343 |
| hERG | 0.004 |
| Ames | 0.027 |
| ROA | 0.081 |
| SkinSen | 0.514 |
| Carcinogencity | 0.384 |
| EI | 0.228 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.053 |
| Antiviral | No |
| Prediction | 0.668046 |